Aniracetam: A Comprehensive Review of This Powerful Nootropic
Aniracetam is a potent nootropic, known for its potential to enhance cognitive functions It belongs to the racetam family, known for their positive effects on the brain and cognitive functions.
Supplement Summary
| Name | Aniracetam |
|---|---|
| Category | Nootropic |
| Main Uses |
|
| Effectiveness | Moderate to High - based on limited human studies and anecdotal evidence |
| Common Dosage | 750-1500 mg daily |
| Price Range | $-$$ |
| Forms Available | Capsules Powder |
Pros
- ✅ Potential to enhance memory and learning
- ✅ May improve mood balance
- ✅ Could boost creativity
- ✅ Potential to improve focus
- ✅ May support mental performance
Cons / Side Effects
- ❌ Possible side effects like headache, nausea, and insomnia
- ❌ Limited human studies
- ❌ Effects may vary between individuals
What Is Aniracetam?
How It Works
Who It's Best For
Who Should Avoid It
Dosage & Usage Tips
Buying Advice & Quality Tips
Price & Value
Final Verdict
Additional Clinical Research
RESEARCH SUMMARY: Aniracetam
KEY FINDINGS:
Cognitive Function Improvement
- Aniracetam treatment resulted in significant improvement in psychobehavioral parameters compared to placebo in patients with mild to moderate Alzheimer's disease.
- Study details: Double-blind, randomized, placebo-controlled trial involving 109 elderly patients over a 6-month period.
Source: Parnetti et al. (1991)
Emotional Stability Enhancement
- Aniracetam monotherapy preserved cognitive function and significantly improved emotional stability in patients with mild cognitive impairment over a 12-month period.
- Study details: Prospective, open-label study with 276 patients, comparing Aniracetam monotherapy, cholinesterase inhibitors, combined treatment, and no treatment groups.
Source: Koliaki et al. (2011)
Neuroprotection in Ischemic Conditions
- Aniracetam attenuated hydroxyl free radical formation in the brains of mice subjected to ischemia-reperfusion, suggesting neuroprotective properties.
- Study details: Experimental study on mice, measuring hydroxyl radical formation and dopamine levels post-ischemia.
Source: Himori et al. (1995)
RESEARCH QUALITY ASSESSMENT:
- The studies employed randomized controlled trials and prospective open-label designs, providing a moderate to high level of evidence.
- Sample sizes varied, with some studies involving over 100 participants, enhancing the reliability of findings.
- Limitations include potential biases in open-label studies and the need for larger, more diverse populations to generalize results.
- Further research is needed to confirm long-term efficacy and safety, as well as to explore mechanisms of action in diverse patient populations.

